Targeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapy

Click to increase image sizeClick to decrease image size

Declaration of interest

P.H. Huang is part of a patent application in relation to methods and materials for treating cancer. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

This work was supported by grants from the Institute of Cancer Research, Cancer Research UK, Sarcoma UK, Royal Marsden Cancer Charity, and BBSRC.